Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-11-000613
Filing Date
2011-11-16
Accepted
2011-11-16 20:31:08
Documents
2
Period of Report
2011-11-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2814
2 O:\DATA\FORMS 3,4&5\KAMDAR, KIM P\2011\KAMDAR111511_CLOVIS-POA.HTM kamdar111511_clovis-poa.htm EX-24 4687
  Complete submission text file 0000904454-11-000613.txt   8891
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Issuer) CIK: 0001466301 (see all company filings)

EIN.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542
Business Address
Kamdar Kim P. (Reporting) CIK: 0001535065 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35347 | Film No.: 111211363